Skip to main content
EXELHealthcare

Exelixis Inc (EXEL) Insider Trading

In the last 90 days, 1 Exelixis Inc (EXEL) insider reported no open-market purchases and 1 sale totaling $526,512. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 10, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 10, 2026Mary C BeckerleCorporate insiderSale9,812$53.66$526,512
Jun 1, 2026Jack L WyszomierskiCorporate insiderSale3,925$50.55$198,409
Jun 1, 2026Sue Gail EckhardtCorporate insiderSale9,812$50.14$491,974
May 26, 2026Dana AftabEVP, Research and DevelopmentSale43,451$50.35$2,187,758
May 20, 2026Patrick J. HaleyEVP, CommercialSale32,110$49.81$1,599,399
May 18, 2026Christopher J. SennerEVP and CFOSale34,901$50.00$1,745,050
May 18, 2026Brenda HeftiSVP and General CounselSale6,625$50.21$332,641
May 7, 2026Mary C BeckerleCorporate insiderSale7,712$48.45$373,646
May 7, 2026Maria C FreireCorporate insiderSale20,634$46.00$949,164
May 7, 2026George PosteCorporate insiderSale60,000$45.71$2,742,600

Common questions

EXEL insider trading FAQ

Are EXEL insiders buying or selling?
Over the last 90 days, EXEL insiders were net sellers, reporting $0.00 of open-market purchases and $526,512 of sales.
When was the last EXEL insider purchase?
No open-market insider purchase of Exelixis Inc stock was reported in the last 90 days.
Where does EXEL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Exelixis Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.